<!DOCTYPE html>
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
		<html lang="ru">
		<meta name="Национальный научный центр фармаконадзора - сообщить о нежелательной или побочной реакции на лекарственный препарат" content="">
		<meta name="apple-mobile-web-app-capable" content="yes">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Национальный научный центр фармаконадзора - сообщить о нежелательной или побочной реакции на лекарственный препарат</title>
		<meta name=description content="В национальном научном центре фармаконадзора вы можете сообщить о нежелательной или побочной реакции на лекарственный препарат и получить консультацию в области лекарственной безопасности">
		<meta name=news_keywords content="заявка, нежелательная реакция, препарат, лекарство, лекарственная безопасность, побочная реакция">
		<meta name=keywords content="заявка, нежелательная реакция, препарат, лекарство, лекарственная безопасность, побочная реакция">
		<link rel="shortcut icon" href="/favicon.ico" type="image/x-icon">
		<link rel="icon" href="/favicon.ico" type="image/x-icon">
		<meta http-equiv="X-UA-Compatible" content="IE=edge">
		<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
		<meta name="format-detection" content="telephone=no">
		<script src="js/jquery-1.11.2.min.js"></script>
		<script src="libs/bootstrap/js/bootstrap.js"></script>
		<script src="js/jquery.magnific-popup.min.js"></script>
		<script src="js/jquery-ui.js"></script>
		<script src="js/common.js"></script>	
		<link rel="stylesheet" href="libs/bootstrap/css/bootstrap-grid.min.css">
		<link rel="stylesheet" href="libs/bootstrap/css/bootstrap.css">
		<link rel="stylesheet" href="libs/bootstrap/css/bootstrap-theme.css">
		<link rel="stylesheet" type="text/css" href="/css/magnific-popup.css"/>
		<link rel="stylesheet" href="//code.jquery.com/ui/1.12.1/themes/base/jquery-ui.css">
		<link rel="stylesheet" href="css/main.css">		
		<link rel="stylesheet" href="css/media.css">
		<link rel="stylesheet" href="css/admika.css">		
		<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed:400,700&amp;subset=cyrillic,cyrillic-ext" rel="stylesheet">
		<link href="https://fonts.googleapis.com/css?family=Roboto:400,700&amp;subset=cyrillic,cyrillic-ext" rel="stylesheet">
		<script src="/js/admika.js"></script>
<meta name="yandex-verification" content="1574edd466a1fa79" />	

	</head>
	<body>
		<!--Header-->
		<header>
			<div class="container">
				<div class="row">
					<div id="fn-header">
						<div class="col-lg-4 col-md-4 col-sm-4 col-xs-12">
							<div id="fn-logo">
								<img src="/images/logo.png" alt="">
							</div>
						</div>
						<div class="col-lg-4 col-md-4 col-sm-4 col-xs-12">
							<div id="fn-headertel">
								<span>8 800 2000333</span>
								<p>Круглосуточно. Бесплатно по России</p>
								<div class="tel-button-wrap">
									<a href="#tel-modal" data-toggle="modal" class="tel-button">Войти</a>
								</div>
							</div>
						</div>
						<div class="col-lg-4 col-md-4 col-sm-4 col-xs-12 call">
							<div id="fn-headercall" class="clearfix">
								<div class="headercall-button">
									<a href="#hidden_form" class="popup_form"><img src="/images/megafon.png"><span>Сообщить <br>
									о нежелательной реакции</span></a>
								</div>
							</div>
							<style>
								.socials{margin-top:15px;text-align:right}
								.socials div{width:42px;height:42px;margin-left:15px;display:inline-block}
								.socials img{width:42px;height:42px;}
								.socials-bottom{margin-top:15px;text-align:left}
								.socials-bottom div{width:42px;height:42px;margin-left:15px;display:inline-block}
								.socials-bottom img{width:42px;height:42px;}
							</style>
							<div class='socials'>
								<div><a href="https://api.whatsapp.com/send?phone=+79037992186&text=Сообщение о нежелательной реакции"><img src=/images/whatsapp.png alt="whatsapp icon"></a></div>
								<div><a href="viber://chat?number=+79037992186"><img src=/images/viber.png alt="viber icon"></a></div>
								<div><a href="tg://msg?text=Сообщение о нежелательной реакции&to=+79037992186"><img src=/images/telegram.png alt="telegrtam icon"></a></div>
							</div>
							<div class='socials' style="text-align: center;">
								<div>+7(903)7992186</div>
							</div>
						</div>
					</div>
				</div>
			</div>
			<hr />
		</header>
		<!--EndHeader-->
		<!--Menu-->
		<section id="fn-topmenu">
			<nav role="navigation" class="navbar navbar-default">
				<div class="container">
					<div class="row">
						<div class="col-lg-12">
							<div class="navbar-header">
								<button type="button" data-target="#navbarCollapse" data-toggle="collapse" class="navbar-toggle">
									<span class="sr-only">Toggle navigation</span>
									<span class="icon-bar"></span>
									<span class="icon-bar"></span>
									<span class="icon-bar"></span>
								</button>
		 					</div>
							<div id="navbarCollapse" class="collapse navbar-collapse">
								<ul class="nav navbar-nav">
									<li class="active"><a>Главная</a></li>
									<li><a href="/about">О нас</a></li>
									<li class="dropdown">
	 									<a data-toggle="dropdown" class="dropdown-toggle" href="#">Информация</a>
										<ul role="menu" class="dropdown-menu">
											<li><a href="/statistika">Статистика</a></li>
											<li><a>Ресурсы</a></li>
										</ul>
									</li>
									<li class="dropdown">
	 									<a data-toggle="dropdown" class="dropdown-toggle" href="#">Услуги ФН</a>
										<ul role="menu" class="dropdown-menu">
											<li><a href="/struktura_fn">Структура ФН</a></li>
											<li><a>База данных</a></li>
										</ul>
									</li>
									<li><a href="/contacts">Контакты</a></li>
									<li class="dropdown">
	 									<a data-toggle="dropdown" class="dropdown-toggle" href="#">Статьи</a>
										<ul role="menu" class="dropdown-menu">
											<li><a href="/drug_safety">Лекарственная безопасность</a></li>
										</ul>
									</li>
								</ul>
							</div>
						</div>
					</div>
				</div>
			</nav>
		</section>

		<!--Presentation-->		
		<section id="presentation">
			<div class="container">
				<div class="row">
					<div class="col-lg-12">
						<div class="slide">							
							<span class="first-slide-top">New legislative requirements to the pharmacovigilance system of the registration certificate holders of the Russian Federation</span>
							<span class="first-slide-bottom">Possibilities of pharmacovigilance<br>outsourcing system </span>
						</div>
						<div class="slide-2 slide">							
							<div class="slide-two-header clearfix">
								<h2>MONITORING OF DRUG SAFETY</h2>
								<hr />
							</div>
							<div class="slide-two-center clearfix">
								<div class="citata">
									<span>Pharmacovigilance</span>								
								</div>
								<p>Pharmacological science and practical activities relating to the <i>collection, detection, assessment, monitoring, and prevention</i> of adverse drug reactions</p>
							</div>	
							<div class="slide-two-bottom">
							<p>Medical products that are in circulation in the Russian Federation are to be monitored of the safety in order to detect the possible negative consequences of their use, warn patients and protect them againts the use of such drugs.</p>
							<span>(Art. 64 of the Federal Law No. 61-FZ dated April 12, 2010 "On the circulation of medicinal products").</span>
							</div>						
						</div>		
						<div class="slide-3 slide">							
							<div class="slide-three-header">
								<h2>REGULATORY AND LEGAL Database OF PHARMACOVIGILANCE</h2>	
							</div>
							<div class="pres-text-block2">
								<ul>
									<li><img src="images/triangle-alpha-green.png"><span>Federal Law No. 61-FZ dated April 12, 2010 “On the circulation of medicinal products”</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Order of the Federal Service for Surveillance in Healthcare (Roszdravnadzor) No. 1071 dated February, 15 2017 “On approval of the procedure for pharmacovigilance”</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Guideline on good pharmacovigilance practices (GVP) of the Eurasian Economic Union, approved by the Council of the Eurasian Economic Commission dated November 3, 2016 No. 87</span></li>									
									<li><img src="images/triangle-alpha-green.png"><span>Good Clinical Practice (GCP), approved by the Council of the ECE dated November 3, 2016 No. 79</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Order of the Ministry of Health of the Russian Federation No. 5539 dated  September 7, 2015 “On approval of the sample quality control of medicinal products for human use”</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Order of the Ministry of Health and Social Development of the Russian Federation No. 758n dated August 26, 2010 “On approval of procedure for the suspension of use of the medical product for human use” (Registered by the Russian Ministry of Justice dated August  31, 2010 No. 18325)</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Russian Ministry of Health order of 26.08.2010 N 749n "On approval of the form of the documents containing the results of safety monitoring of the medicinal products for medical use with the aim of confirming its state of the  registration"</span></li>
									<li><img src="images/triangle-alpha-green.png"><span>Russian Ministry of Health order of 07.09.2016 №682n "On approval of the form of the documents containing the results of monitoring the efficacy and safety of the medicinal product for the medical use conducted by the holder or by the owner of the registration certificate of a medical or deprived legal entity"</span></li>
									<li><span>National standard “Appropriate Clinical Practice. GOST R 52379-2005”, approved by the Order of the Russian Technical Regulation System No. 232-s dated September, 2005.</span></li>
								</ul>
							</div>
						</div>
						<div class="slide-4 slide">							
							<div class="slide-three-header">
								<h2>Regulatory measures in detection of drug safety issues</h2>	
							</div>
							<div class="pres-text-block2">
								<ul>
									<li><img src="images/triangle-b-w.png"><span>Cancellation of registration (Art. 34.1 of the Federal Law “On the circulation of medicinal products”)</span></li>
									<li><img src="images/triangle-b-w.png"><span> Suspension of the circulation (Art. 65.1 of the Federal Law “On the circulation of medicinal products”)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Changes to the instruction for human use (order of the Federal Service for Surveillance in Healthcare No. 1071 dated  February 15, 2017)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Changes to the Protocol of clinical trial*</span></li>
									<li><img src="images/triangle-b-w.png"><span>Suspension of clinical trials*</span></li>
									<li><img src="images/triangle-b-w.png"><span>Request for Risk Management Plan (RMP)*</span></li>
									<li><img src="images/triangle-b-w.png"><span>Suspension of the circulation or use of the medicinal product for additional study period*</span></li>
									<hr />
									<span class="comment">*Order of the Federal Service for Surveillance in Healthcare No. 1071 dated  February 15, 2017</span>									
								</ul>
							</div>
							<div class="slide-three-header">
								<h2>Sanctions in case of absence of the pharmacovigilance system on the manufactory</h2>	
							</div>
							<div class="pres-text-block2">
								<ul>
									<li><img src="images/triangle-b-w.png"><span>Cancellation of state registration of the medicinal product (Art. 34.9 of the Federal Law “On the circulation of medicinal products”)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Suspension of use of the medicinal product (Art. 65.2 of the Federal Law “On the circulation of medicinal products”)</span></li>
									<li><img src="images/triangle-b-w.png"><span>Administrative responsibility</span></li>
									<li><img src="images/triangle-b-w.png"><span>Criminal responsibility (the Criminal Code of the Russian Federation, Art. 238 “Production, storage, transportation or sale of goods and products, performance of the works or services not meeting safety requirements)</span></li>
								</ul>
							</div>
						</div>
						<div class="slide-5 slide">							
							<div class="slide-five-header">
								<img src="images/logo.png">
								<h2>ADDITIONAL REGULATORY REQUIREMENTS OF  OF THE EURASIAN ECONOMIC UNION</h2>	
							</div>
							<div class="pres-text-block2">
								<ol>
									<li><span>Harmonisation of the pharmacovigilance system of the Russian Federation with GVP, GCP of the Eurasian Economic Union and EU GVP;</span></li>
									<li><span>The obligation to provide the Master file by request from Federal Service for Surveillance in Healthcare;</span></li>
									<li><span>The requirement for the presence of the Pharmacovigilance Officer on Eurasian Economic Union;</span></li>
									<li><span>Requirements for screening local scientific literature;</span></li>
									<li><span>Possible laboratory control of drugs if we got adverse reactions in sample test;</span></li>
									<li><span>Requirements to training local staff on pharmacovigilance;</span></li>
									<li><span>Possible to request RMP  of registered drugs before implementation of risk management measures;</span></li>
									<li><span>Requirements to create risk management programs considering specific Federal Service for Surveillance in Healthcare </span></li>
									<li><span>Impossibility of copying European PSUR</span></li>
									<li><span>Informing regulators by holders of registration certificates about important changes to the pharmacovigilance system;</span></li>
									<li><span>Planned and extraordinary inspection pharmacovigilance system;</span></li>
									<li><span>The appointment of post-marketing clinical trials;</span></li>
									<li><span>Requirements for informing doctors and consumers about the new data safety of drugs</span></li>
								</ul>
							</div>
						</div>
						<div class="slide-6 slide">							
							<div class="pres-text-block">
								<strong>INDEPENDENT CREATION OF THE PHARMACOVIGILANCE SYSTEM</strong>							
								<ul>
									<li><span>Prepare pharmacovigilance system master file;</span></li>
									<li><span>Appoint the Pharmacovigilance Officer  and notify the Federal Service for Surveillance in Healthcare;</span></li>						
									<li><span>Educate Pharmacovigilance Officer and all employees;</span></li>
									<li><span>Create standard operating procedures (SOP) for the main pharmacovigilance processes based on the company's quality management system;</span></li>
									<li><span>Provide the implementation of the SOP leaving a documentary trace;</span></li>
									<li><span>Provide a continuous and qualitative analysis of the balance of benefits and risks of drugs;</span></li>
									<li><span>Organize the work of an electronic database of  adverse drug reaction;</span></li>
									<li><span>Organize the collecting, analysis and evaluation of adverse drug reaction's data;</span></li>
									<li><span>Provide a scientific literature screening;</span></li>
									<li><span>Prepare periodic security reports in a new format (PSUR);</span></li>
									<li><span>Self-detection and drug safety signal processing;</span></li>
									<li><span>Independent development of drug risk management plans and strategy;</span></li>
									<li><span>Provide a full and timely submission of responses to regulatory requests;</span></li>
									<li><span>Providing regular audits (self-testing);</span></li>
									<li><span>Preparing for inspections of regulatory organs (external audits – since 2017)</span></li>
								</ul>
							</div>
							<div class="row">
								<div class="col-lg-3 col-md-3 col-sm-3">								
									<img src="images/man-big.png" class="man">
								</div>
								<div class="col-lg-9 col-md-9 col-sm-9 col-xs-12">
									<div class="risks">										
										<h3>RISKS OF CERTIFICATE HOLDERS</h3>
										<ul>
											<li><span>* NO EXPERIENCE, QUALIFICATIONS OF SPECIALISTS</span></li>
											<li><span>* DEFICITE OF STAFF</span></li>
											<li><span>* 1 OR 2 BRAND IN THE PRODUCT PRODUCTION PORTFOLIO</span></li>
											<li><span>* REQUIREMENTS FOR SAFETY AND EFFICIENCY ASSESSMENT</span></li>
											<li><span>* AVAILABILITY OF SOFTWARE FOR EVALUATION BENEFIT / RISK</span></li>
											<li><span>* HUGE AMOUNT OF ORGANIZATIONAL WORK AND DOCUMENTATION</span></li>
											<li><span>* NECESSITY OF THE USE OF ADDITIONALLY CHARGED RESOURCES OF THE INFORMATION</span></li>
										</ul>
									</div>
								</div>
							</div>
						</div>
						<div class="slide slide-7">
							<strong>SERVICES OF ANO “NATIONAL PHARMACOVIGILANCE RESEARCH CENTER”</strong>
							<table>
								<tr class="td-dark">									
									<td>Title</td>
								</tr>
								<tr class="td-light">								
									<td>Creation and maintenance of documentation of the pharmacovigilance (Master file, SOPs, instructions, positions, etc.)</td>
								</tr>
								<tr class="td-middle">								
									<td>Appointment of a qualified Pharmacovigilance Officer</td>
								</tr>
								<tr class="td-light">									
									<td>24 hours call-center organization for adverse reaction reports receiving</td>
								</tr>
								<tr class="td-middle">									
									<td>Organization of the collecting of reports about side effects and non-efficacy of the medicinal products, using free and paid scientific databases of  the Russian Federation and countries of circulation including English-speaking countries</td>
								</tr>
								<tr class="td-light">									
									<td>Analysis, evaluation, and storage of all the reports of adverse reactions, organization of an electronic automated system for recording, processing, and storing of drug safety information</td>
								</tr>
								<tr class="td-middle">									
									<td>Organization of operative collecting of additional information about a side effect in case of a serious adverse reaction, also using information collecting programs</td>
								</tr>
								<tr class="td-light">									
									<td>Scientific assessment, assessment of the benefit / risk of using an automated system, including routine and 200 additional indicators</td>
								</tr>
								<tr class="td-middle">									
									<td>Preparing and writing of  periodic safety update report (PSUR)</td>
								</tr>
								<tr class="td-light">									
									<td>Preparing and evaluation of the risk management system; the risk management planning (RMP)</td>
								</tr>
								<tr class="td-middle">									
									<td>Development and conducting of trainings for pharmacovigilance employees</td>
								</tr>
								<tr class="td-light">									
									<td>Preparing to audits and inspections of the Federal Service for Surveillance in Healthcare of the Russian Federation (Roszdravnadzor)</td>
								</tr>
								<tr class="td-middle">									
									<td>Organization of the system of the healthcare professionals and patients informing about the drug safety</td>
								</tr>
								<tr class="td-light">									
									<td>Implementation of obligations to the authorized organs of states-member of the Eurasian Union in terms of  adverse reaction information collecting, periodic reporting, inquiry answer providing</td>
								</tr>
							</table>							
						</div>	
						<div class="slide slide-8-add">
							<div class="slide-three-header">
								<h2>Free activities</h2>	
							</div>
							<div class="pres-text-block2">
								<ul>
									<li><img src="images/triangle.png"><span>Free webinars on the pharmacovigilance system organization of the drug manufacturer</span></li>
									<li><img src="images/triangle.png"><span>Free audit of the current pharmacovigilance system of the drug manufacturer</span></li>
									<li><img src="images/triangle.png"><span>Announcements of activities are presented on the site
									<a href="http://www.drug.safety.ru/">www.drug.safety.ru</a></span></li>
									<li><img src="images/triangle.png"><span>Free phone numbers: 8-800-777-86-04, 8(495)799-2186</span></li>
								</ul>
							</div>
						</div>
						<div class="slide slide-8">
							<strong>FORMAT OF COOPERATION - THE CONCLUSION OF THE OUTSOURCING CONTRACT</strong>
							<div class="row">
								<div class="col-lg-12 col-xs-12">
									<img src="images/slide-8.png">							
								</div>
							</div>
						</div>
						<div class="slide slide-9 custom">
							<img src="images/slide-9.png">
							<strong>ICSR ASSESSMENT (STANDARD VS. NRSP METHODS)</strong>
							<div class="slide-9-middle">
								<div class="slide-9-left">
									<p><strong>Patient`s info</strong> (except those indicated in yellow card: age in days, months and years, diagnosis in ICD 10 codes, age categories and self-treatment cases)
									ADR info (duration, leading clinical manifestations, type according to WHO, Rawlins-Thompson, Will-Brawn, DoTS; severity according to Karch-Lasagna, LDS, Hartwig-Siegel and CTCAE, preventability according to Hallas, Granada test and Schumock-Tornton, MedDRA codes)
									</p>
									<p><strong>Suspected drug`s info</strong> (duration of therapy before ADR, ATC codes, presence in local formularies and recommendations, State Register of Medicinal Products, List of Life-Saving and Necessary Medicinal Products)</p>
									<p><strong>Info about other (concomitant) drugs</strong> (ATC codes, Causality assessment according to Horn-Hansten, interaction checker)</p>
									<p><strong>Reporter`s info</strong> (info about medical organization and WHO criteria for it)</p>
									<p><strong>Causality assessment</strong> (Naranjo and Karch-Lasagna methods)</p>
									<p><strong>Integral method</strong> – assessment of drug related problems (DRP, incl. local modification)</p>
									<p><strong>Agreement analysis</strong> for methods (during assessment of severity and preventability) and for experts</p>
									<p><strong>Search and evaluation of “Off Label” prescriptions</strong> (age restrictions, ignoring of contraindications, dosing, frequency and duration of therapy)</p>
								</div>
								<div class="slide-9-right">
									<p><strong>Patient`s info</strong> (gender, age, pregnancy/lactation, consequences, clinical diagnosis, allergy anamnesis, hospital stay and domestic use of medications)</p>
									<p><strong>ADR info</strong> (dates of beginning and finishing, description, categories, seriousness)</p>
									<p><strong>Suspected drug`s info</strong> (trade name, INN, manufacturer and MAH, indications, single dose, frequency,  route of introduction, batch/lot number, start date for therapy and date of its end)</p>
									<p><strong>Info about other (concomitant) drugs</strong> (trade name, INN, dosing, routes of introduction and duration of therapy)</p>
									<p><strong>Information about correction</strong></p>
									<p><strong>Reporter`s info</strong> (name, position, date of form filling)</p>
									<p><strong>Causality assessment performed by doctor</strong> (if any)</p>
								</div>
							</div>							
						</div>
						<div class="slide slide-10">
							<strong>EXAMPLES OF SAFETY DATA AUTOMATIC PROCESSING</strong>
							<div class="row">
								<div class="col-lg-5 col-md-5 col-sm-6 col-xs-12">									
									<img src="images/slide-10-left.png">
								</div>
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<img src="images/slide-10-right.png">
								</div>
							</div>
							<span>We use WHO, Rawlins-Thompson, Will-Brawn and DoTS classifications</span>						
						</div>	
						<div class="slide slide-11">
							<strong>EXAMPLES OF DATABASE RESULTS (ATC GROUPS)</strong>
							<div class="row">
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<img src="images/slide-11.png">
								</div>
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<span>We can perform analysis in different groups, incl. all levels of ATC classification </span>
								</div>
							</div>												
						</div>		
						<div class="slide slide-12">
							<strong>EXAMPLES OF DATABASE RESULTS</strong>
							<div class="row">
								<div class="col-lg-10">
									<img src="images/slide-12.png">
								</div>								
							</div>												
						</div>
						<div class="slide slide-13">
							<strong>EXAMPLES OF DATABASE RESULTS (SEVERITY ASSESSMENT)</strong>
							<div class="row">
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<p>LDS points</p>
									<img src="images/slide-13-left.png">
								</div>
								<div class="col-lg-6 col-md-6 col-sm-6 col-xs-12">
									<img src="images/slide-13-right.png">
								</div>
							</div>
							<span>Use NCI – CTCAE 4.03 if necessary</span>						
						</div>
						<div class="slide slide-14">
							<strong>EXAMPLES OF DATABASE RESULTS (CAUSALITY ASSESSMENT)</strong>
							<div class="row">
								<div class="col-lg-11">
									<img src="images/slide-14.png">
								</div>	
								<span>For cause-and-effect relation automatized assessment different scales and algorithms are used (Naranjo, Karch-Lasagna, Horn-Hansten, RUCAM, ALDEN and others)</span>	
							</div>												
						</div>	
						<div class="slide slide-15">
							<strong>EXAMPLES OF DATABASE RESULTS (PREVENTABILITY ASSESSMENT)</strong>
							<h3>Adverse reaction prevention assessment</h3>
							<div class="row">
								<div class="col-lg-11">
									<img src="images/slide-15.png">
								</div>														
							</div>												
						</div>										
						<div class="slide slide-16">							
							<h2>WELCOME FOR COLLABORATION</h2>
							<div class="slide-16-block">
								<a href="http://WWW.DRUGSAFETY.RU" class="link-site">WWW.DRUGSAFETY.RU</a>
								<a href="mailto:INFO@DRUGSAFETY.RU" class="link-email">INFO@DRUGSAFETY.RU</a>
								<span>8 800 7778604</span>
								<span>+7(495)799-2186</span>
							</div>
						</div>					
					</div>
				</div>
			</div>
		</section>

		<!--Footer-->
		<footer id="fn-footer">
			<hr />
			<div class="container">
<div class='socials-bottom'>
								<div><a href="https://api.whatsapp.com/send?phone=+79037992186&text=Сообщение о нежелательной реакции"><img src=/images/whatsapp.png alt="whatsapp icon"></a></div>
								<div><a href="viber://chat?number=+79037992186"><img src=/images/viber.png alt="viber icon"></a></div>
								<div><a href="tg://msg?text=Сообщение о нежелательной реакции&to=+79037992186"><img src=/images/telegram.png alt="telegrtam icon"></a></div>
							</div>
		<div class="row">
				<div class="col-lg-12 col-md-12">
					<div class="footercontacts">
						<div class="row">
							<div class="col-lg-4 col-md-4 col-sm-6">
								<div class="footercontact footercontact-office clearfix">
									<h5>Офис</h5>									
									<span>
Москва<br/>Малая Сухаревская площадь<br />д.2,корп.2.
</span>										
								</div>
							</div>
							<div class="col-lg-4 col-md-4 col-sm-6">
								<div class="footercontact footercontact-phone clearfix">
									<h5>Телефон</h5>									
									<strong>+7(495)799-2186</strong></span>									
								</div>
							</div>
							<div class="col-lg-4 col-md-4 col-sm-6">
								<div class="footercontact footercontact-email clearfix">
									<h5>E-mail</h5>									
									<a href="mailto:info@drugsafety.ru">info@drugsafety.ru</a>
								</div>
							</div>							
						</div>
					</div>
				</div>				
			</div>
			<div class="row">
				<div class="col-lg-12 col-xs-12 footertext">
					<span>© 2017 Фармаконадзор<br>Все права защищены</span>
				</div>
		</div>
			</div>
		</footer>
		<!--EndFooter-->
		<div class="hidden">
			<form id="hidden_form" action="/main_form">
				<div>
					<input type="checkbox" name="disclaim"><p>Нажимая кнопку продолжить, вы даете согласие на обработку своих персональных данных</p>
				</div>
				<div class="butt-dis">
					<a href="/main_form" id="block" class="disabled">Продолжить</a>
				</div>
				</div>
			</form>
		</div>
		<div class="modal" id="tel-modal">
			<div class="modal-dialog"> 
	  			<div class="modal-header">	  				
	    			<button class="close" data-dismiss="modal">×</button>	    			
	    			<h3>Авторизация</h3>
	  			</div>
	  			<div class="modal-body">
	  				<span id="tel-header-form">
		    			<input type="text" id="modal-login" name="tel-login" onkeyup="checkParams()" placeholder="Введите логин" required="">
		    			<input type="text" id="modal-pass" name="tel-pass" onkeyup="checkParams()" placeholder="Введите пароль" required="">
		    			<button type="submit" id="button-header-form" class="disabled">Отправить</button>
		    		</span>	
		    		<div class="modal-links clearfix">
		    			<a href="#" class="reg">Регистрация</a>
		    			<a href="#" class="pass">Забыли пароль?</a>
		    		</div>
	  			</div>	  			
	  		</div>
		</div>
	<!-- Yandex.Metrika counter -->
	<script type="text/javascript">
	    (function (d, w, c) {
	        (w[c] = w[c] || []).push(function() {
	            try {
	                w.yaCounter44141314 = new Ya.Metrika({
	                    id:44141314,
	                    clickmap:true,
	                    trackLinks:true,
	                    accurateTrackBounce:true
	                });
	            } catch(e) { }
	        });
	        var n = d.getElementsByTagName("script")[0],
	            s = d.createElement("script"),
	            f = function () { n.parentNode.insertBefore(s, n); };
	        s.type = "text/javascript";
	        s.async = true;
	        s.src = "https://mc.yandex.ru/metrika/watch.js";
	        if (w.opera == "[object Opera]") {
	            d.addEventListener("DOMContentLoaded", f, false);
	        } else { f(); }
	    })(document, window, "yandex_metrika_callbacks");
	</script>
	<noscript><div><img src="https://mc.yandex.ru/watch/44141314" style="position:absolute; left:-9999px;" alt="" /></div></noscript>
	<!-- /Yandex.Metrika counter -->
	</body>
</html>